List of speakers

More to come…

Roxana O Carare, Southampton, UK

Preclinical evaluation of a novel anti-tau vaccine based on UBITh peptide technology

Ilse Dewachter, Hasselt, Belgium

Michel Goedert, Cambridge, UK

Jürgen Götz, Brisbane, Australia

Tau in Alzheimer’s disease – from pathomechanistic studies to therapeutic ultrasound as a treatment modality

Bernard Hanseeuw, Louvain, Belgium

Eckhard Mandelkow, Germany

Pierre Maquet, Liège, Belgium

Ana Melo de Farias, Brazil & France

Alzheimer’s risk gene PTK2B effects TAU phosphorylation in human induced neurons

Leonard Petrucelli, FL, USA

TMEM106b and tau

Wiep Scheper, Amsterdam, NL

Maria Grazia Spillantini, Cambridge, UK

Patrik Versteken, Leuven, Belgium

Susanne Wegmann, Berlin, Germany